This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Brl Medicine Inc., East China Normal University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
1 out of 73 
Years Active: 2026
Title: Dali Li: Innovator in Gene Editing Technologies
Introduction
Dali Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of gene editing, holding a total of 2 patents. His work focuses on enhancing the efficiency of gene integration and editing processes.
Latest Patents
Dali Li's latest patents include groundbreaking innovations such as "SGRNA Guiding PD1 Gene for Cleavage to Achieve Efficient Integration of Exogenous Sequences" and "Fusion Protein That Improves Gene Editing Efficiency and Application Thereof." These patents reflect his commitment to advancing genetic research and technology.
Career Highlights
Throughout his career, Dali Li has worked with notable organizations, including Brl Medicine Inc. and East China Normal University. His experience in these institutions has allowed him to develop and refine his innovative ideas in gene editing.
Collaborations
Dali Li has collaborated with esteemed colleagues in his field, including Mingyao Liu and Xiaohui Zhang. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Dali Li is a key figure in the realm of gene editing, with a focus on improving the efficiency of genetic technologies. His patents and collaborations highlight his dedication to innovation in this critical area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile